共 50 条
- [31] LONG-TERM FOLLOW-UP OF REFRACTORY SYSTEMIC VASCULITIS TREATED WITH RITUXIMAB [J]. RHEUMATOLOGY, 2010, 49 : I123 - I123
- [32] Long-term follow-up of refractory systemic vasculitis treated with RTX [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 164 : 64 - 65
- [33] Azathioprine as compared to cyclophosphamide maintenance therapy for ANCA-associated vasculitis is associated with increased long-term relapse risk [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 2005, 28 (03): : 195 - 195
- [35] The long-term prognosis of patients with ANCA-associated vasculitis with renalinvolvement [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 2005, 28 (02): : 88 - 88
- [36] Risk of malignancy with long-term immunosuppression in ANCA-associated vasculitis [J]. PRESSE MEDICALE, 2013, 42 (04): : 767 - 767
- [37] Long-term outcomes in elderly patients with ANCA-associated vasculitis [J]. RHEUMATOLOGY, 2020, 59 (05) : 1076 - 1083
- [38] Good long-term results for rituximab in ANCA-associated vasculitis [J]. Nature Clinical Practice Rheumatology, 2007, 3 (2): : 64 - 65
- [39] RICKETS ASSOCIATED WITH LONG-TERM ANTICONVULSANT THERAPY [J]. PEDIATRICS, 1977, 60 (02) : 261 - 262